Gabelli Funds' 2nd PFAS Symposium
Logotype for 374Water Inc

374Water (SCWO) Gabelli Funds' 2nd PFAS Symposium summary

Event summary combining transcript, slides, and related documents.

Logotype for 374Water Inc

Gabelli Funds' 2nd PFAS Symposium summary

9 Jul, 2026

Technology and innovation in PFAS destruction

  • Transitioning from traditional waste disposal to destruction technologies is critical for addressing PFAS contamination, as legacy methods like incineration and landfills only relocate the problem without destroying contaminants.

  • AirSCWO, a proprietary supercritical water oxidation technology, destroys organic waste streams, meeting or exceeding EPA standards, and is designed to be both an augmentation and a replacement for existing waste management processes.

  • The technology is exothermic, generating energy that can be reused within facilities or supplied to the power grid, and is capable of processing a wide range of organic contaminants from biosolids, landfill leachate, firefighting foam, and industrial waste.

  • Modular and mobile units, ranging from one to 200 tons per day, are being developed to address diverse customer needs, with current deployments including a six-ton unit operational in Orlando and plans for larger bespoke systems starting in 2025.

  • The company is scaling up R&D and manufacturing, doubling its lab size, and engaging in demonstration contracts with municipalities, federal agencies, and industrial partners.

Market opportunity and commercialization strategy

  • The addressable global market for PFAS and organic waste destruction is estimated at $250 billion, with a $1.6 billion identified pipeline in the U.S. alone, including contracts with municipal and federal entities.

  • There are approximately 16,000 municipal wastewater treatment plants in the U.S., all facing PFAS challenges, and the company is targeting municipal, federal, industrial, and commercial markets.

  • Strategic partnerships, such as with Merrell Bros., have enabled on-site technology development and scaling, while revenue-sharing opportunities with TSDF facilities are being pursued.

  • The commercialization timeline anticipates initial commercial scale within 12–18 months, with revenue growth expected in 2025 and a target for cash flow positivity by 2027.

  • Projected revenues for 2025 are around $26 million, with continued investment in engineering, manufacturing, and R&D to support rapid scaling and market penetration.

Regulatory and industry context

  • Regulatory momentum, including new EPA standards and increased litigation risk, is driving demand for effective PFAS destruction solutions.

  • The EPA has set enforceable standards for PFAS in drinking water and designated key PFAS as hazardous substances under CERCLA, compelling polluters to fund remediation.

  • Federal funding, such as $10 billion from the Bipartisan Infrastructure Law, is supporting PFAS treatment infrastructure, with most applicants focusing on drinking water solutions.

  • The EPA is coordinating with multiple federal agencies and states to address PFAS through research, regulation, and enforcement, emphasizing equity and environmental justice.

  • Industry innovation, driven by regulation, is expected to lower costs and expand domestic capacity for PFAS treatment technologies.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more